Back to search

Enhanced Immunological Tolerance against Allograft Rejection by Oral Administration of Allogeneic Antigen Linked to Cholera Toxin B Subunit

Data up to Jan 2025

Published2000
Citations24
References30

Total Citations Per Year

Abstract

References (30)

Oral Tolerance: Immunologic Mechanisms and Treatment of Animal and Human Organ-Specific Autoimmune Diseases by Oral Administration of Autoantigens

1994 • 895 citations

Oral tolerance: immune mechanisms and treatment of autoimmune diseases

1997 • 757 citations

Induction of anergy or active suppression following oral tolerance is determined by antigen dosage.

1994 • 643 citations

The JAM test A simple assay for DNA fragmentation and cell death

1991 • 632 citations

Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy.

1991 • 450 citations

Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance.

1994 • 317 citations

A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes

1997 • 231 citations

IL-4 is a differentiation factor for transforming growth factor-β secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis

1998 • 218 citations

Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit.

1996 • 198 citations

T helper 2 cells are subject to high dose oral tolerance and are not essential for its induction.

1995 • 171 citations

Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat.

1992 • 163 citations

Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development.

1989 • 161 citations

T cell regulation in adult transplantation tolerance.

1996 • 144 citations

ORAL, BUT NOT INTRAVENOUS, ALLOANTIGEN PREVENTS ACCELERATED ALLOGRAFT REJECTION BY SELECTIVE INTRAGRAFT TH2 CELL ACTIVATION

1993 • 124 citations

BREAST FEEDING AND MATERNAL-DONOR RENAL ALLOGRAFTS

1984 • 120 citations

Type 2 helper T cell-type cytokines and the development of "infectious" tolerance in rat cardiac allograft recipients.

1997 • 119 citations

Concepts in Vaccine Development

1996 • 95 citations

DOWN-REGULATION OF THE IMMUNE RESPONSE TO HISTOCOMPATIBILITY ANTIGENS AND PREVENTION OF SENSITIZATION BY SKIN ALLOGRAFTS BY ORALLY ADMINISTERED ALLOANTIGEN1

1992 • 89 citations

Treatment of experimental autoimmune arthritis by nasal administration of a type II collagen-cholera toxoid conjugate vaccine

1999 • 61 citations

Combined anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model.

1993 • 57 citations

Induction of oral tolerance in TGF-beta 1 null mice.

1998 • 54 citations

Intranasal Administration of aSchistosoma mansoniGlutathioneS-Transferase-Cholera Toxoid Conjugate Vaccine Evokes Antiparasitic and Antipathological Immunity in Mice

1999 • 51 citations

Immunologic Benefits and Hazards of Milk in Maternal-Perinatal Relationship

1975 • 48 citations

ALLOREACTIVE DELAYED-TYPE HYPERSENSITIVITY IN GRAFT RECIPIENTS

1997 • 47 citations

Induction of Oral Tolerance in TGF-β1 Null Mice

1998 • 45 citations

Oral immunisation as a strategy for enhancing corneal allograft survival

1997 • 37 citations

Improved Methods for Transplanting Split-heart Neonatal Cardiac Grafts Into the Ear Pinna of Mice and Rats

1998 • 20 citations

Immunologic phenotype of hosts orally immunized with corneal alloantigens.

1998 • 17 citations

Priming or Tolerization of the B- and Th2-Dependent Immune Response by the Oral Administration of OVA-DNP Is Determined by the Antigen Dosage

1998 • 17 citations

3.8. Oral Vaccination, Mucosal Immunity and Oral Tolerance with Special Reference to Cholera Toxin

1996 • 14 citations

Cited By (0)

No citing papers found in database

Enhanced Immunological Tolerance against Allograft Rejection by Oral Administration of… (2000) – Clinical Immunology | Metascience Observatory Explorer